Sirnaomics (HKSE:02257) Net Income From Continuing Operations : HK$-392.17 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Sirnaomics's net income from continuing operations for the six months ended in Dec. 2024 was HK$-52.49 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-392.17 Mil.

Sirnaomics Net Income From Continuing Operations Historical Data

The historical data trend for Sirnaomics's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirnaomics Net Income From Continuing Operations Chart

Sirnaomics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

-359.91

-1,684.07

-758.13

-663.76

-390.57

Sirnaomics Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Income From Continuing Operations	Get a 7-Day Free Trial					-399.22	-321.98	-342.73	-339.68	-52.49

Sirnaomics Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-392.17 Mil.

Sirnaomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

V5Z:Germany

Address

No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN

Website

https://www.sirnaomics.com

Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.

Executives

Lu Yang	2101 Beneficial owner
Poon Hung Fai	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Dai Xiaochang	2201 Interest of corporation controlled by you
Yan Xia Ling	2202 Interest of your spouse
Ceng Yu	2201 Interest of corporation controlled by you
Li Jie	2201 Interest of corporation controlled by you
Li Lele	2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp)	2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you

Sirnaomics Headlines

No Headlines